VITALE, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 4.239
Totale 4.239
Nazione #
IT - Italia 4.239
Totale 4.239
Città #
Genova 3.393
Rapallo 501
Genoa 331
Bordighera 14
Totale 4.239
Nome #
Human NK cells at early stages of differentiation produce large amounts of CXCL8 and express CD161 molecule that that functions as an activating receptor 137
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 134
Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. 132
IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors 129
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. 128
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells. 125
"Physiological and Pathological Aspects of Human NK Cells" 121
Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors. 121
Human innate lymphoid cells 120
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 119
Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells 119
MSC and innate immune cell interactions: A lesson from human decidua 117
Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation 116
NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation 113
Cytolytic T lymphocytes displaying Natural Killer (NK)-like activity. Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production 112
Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. 107
Effect of tyrosin kinase inhibitors on NK Cell and ILC3 development and function 107
HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells. 105
HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. 104
Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells 104
Plasticity of NK-cell differentiation 103
Il-1β-Releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from cd34+ precursors 101
Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells 96
p75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells 91
Human Natural Killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors. 90
Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor 90
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation 90
Isolation, Expansion, and Characterization of Natural Killer Cells and Their Precursors as a Tool to Study Cancer Immunosurveillance 90
HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells 89
Analysis of the activating receptors and cytolytic function of human Natural Killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation 88
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. 88
Cytokine-induced expression of killer inhibitory receptors in human T lymphocytes 83
HLA class-I-specific inhibitory receptor in human T lymphocytes: interference with T-cell functions 83
Analysis of the circulating Th1/Th17 lymphocyte repertoire after hematopoietic stem cell transplant may reveal opportunistic fungal infections rather than GvHD reaction 81
The corticosteroid-induced inhibitory effect on NK cell function reflects downregulation and/or disfunction of triggering receptors involved in natural cytotoxicity. 78
Expression of HLA class I-specific inhibitory receptors by chronically activated cytolytic T lymphocytes: useful or harmful to the host? 77
Human decidua contains NK cell committed CD34+ hematopoietic precursors able to differentiated into functional Natural Killer cells 72
Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes 69
Human innate lymphoid cells: Their functional and cellular interactions in decidua 68
CXCL8 production and absence of LFA-1 surface expression identify human NK cells at early stages of differentiation characterized by CD161 molecule with activating function 66
In vivo generation of patient-specific cytotoxic T cell clones (CTL), following donor lymphocyte infusions (DLI) for chronic myeloid leukemia after HLA genotypically identical BMT 66
EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34+ Cells 52
In vivo generation of patient-specific cytotoxic T cell clones (CTL), following donor lymphocyte infusions (DLI) for chronic myeloid leukemia after HLA genotypically identical BMT 51
Analysis of KIR expression in NK cells recovery after MUD or SIB BMT 45
Targeted therapies: Friends or foes for patient's NK cell-mediated tumor immune-surveillance? 39
Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise? 12
Murine models to study human NK cells in human solid tumors 12
Totale 4.340
Categoria #
all - tutte 11.653
article - articoli 10.351
book - libri 0
conference - conferenze 587
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 715
Totale 23.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019233 0 0 0 0 0 0 0 0 0 0 131 102
2019/20201.256 72 33 51 84 111 122 167 86 108 229 148 45
2020/2021363 24 31 28 34 14 28 22 45 33 37 30 37
2021/2022569 23 37 39 52 18 40 23 139 32 50 33 83
2022/2023588 48 58 8 57 87 112 1 40 82 1 88 6
2023/2024263 18 34 9 57 30 40 18 19 28 10 0 0
Totale 4.340